Участник:Aboshedab: различия между версиями

Материал из FIJTeam Project Wiki
Перейти к навигации Перейти к поиску
>Aboshedab
Нет описания правки
>Aboshedab
Нет описания правки
Строка 1: Строка 1:
== Overview ==
=== Overview ===


Cloning, specifically '''postmortem cloning''' is the process in which a genetically identical copy of a person is produced from their genetic material, usually collect once the individual is deceased. Originally a technological feat invented by the Jargon Federation, it has now become a commercialized procedure as of 2461 following extensive testing by government and private entities.
Cloning, specifically '''postmortem cloning''' is the process in which a genetically identical copy of a person is produced from their genetic material, usually collect once the individual is deceased. Originally a technological feat invented by the Jargon Federation, it has now become a commercialized procedure as of 2461 following extensive testing by government and private entities.

Версия от 22:10, 31 января 2020

Overview

Cloning, specifically postmortem cloning is the process in which a genetically identical copy of a person is produced from their genetic material, usually collect once the individual is deceased. Originally a technological feat invented by the Jargon Federation, it has now become a commercialized procedure as of 2461 following extensive testing by government and private entities.

History

The entrance of postmortem cloning technology for Humanity occurred when Zeng-Hu Pharmaceuticals were able enter a cooperative research agreement as of 2419 following extensive negotiation with the Jargon Federation, with the first viable model being produced three years later patented by Zeng-Hu Pharmaceuticals. What followed was extensive cloning trials using test subjects and willing participants using numerous methods of cloning, all in effort to find the most suitable method of cloning. In effort to increase the pace of the research and reaching a larger sample of potential participants, Zeng-Hu signed numerous contracts to allow for further cooperative research while maintaining the sole patent holder on this technology.

As the end of 2460 approached, it was believed that the best method was found, ending this long tine of testing and entering the commercialization phase, which saw Zeng-Hu reap significant capital by retailing this technology to numerous facilities that could afford it across the galaxy. Presently cloning technology remains the crown jewel of Zeng-Hu's research, a source of pride to its employees.